FierceHealthcareFierceHealthITFierceHealthFinance   FiercePharmaFierceBiotechFierceSarbox
Syndicate content

Abbott Laboratories news from FierceHealthcare

Most Popular Abbott Laboratories story
Related Tags Boston Scientific   Guidant   stents   Medtronic
Tools

News

ALSO NOTED: States sue Abbott, claiming it blocked generics; SEC helps troubled hospital bond holders; and much more...

March 19, 2008 — 7:59am ET
> Eighteen states are suing Abbott Laboratories, saying it blocked generic competition for its popular cholesterol medication TriCor. Read more...

Trend: Heart stent maker markets directly to patients

December 5, 2007 — 7:59am ET
Here's something you don't see every day. A heart stent manufacturer, Johnson & Johnson subsidiary Cordis Corp., is mounting a national marketing campaign aimed directly at consumers--an unusual... Read more...

ALSO NOTED: Judge supports Abbott in latest stent dispute; Statins recommended for kids; and much more...

August 8, 2007 — 6:59am ET
> A federal judge ruled a 2006 settlement between Abbott Laboratories and Israel's Medinol Ltd. gives Abbott wide latitude to sell drug-coated stents in the U.S. Read more...

ALSO NOTED: General Electric ends Abbott buyout plan; Tobacco interests get states to cut back on anti-smoking ads; and much mo

July 13, 2007 — 6:59am ET
> General Electric Co. has ended its effort to acquire Abbott Laboratories' in-vitro and point of care diagnostics businesses, which had 2006 sales of $2.7 billion. Read more...

JPMorgan, GE make healthcare acquisitions

January 17, 2007 — 8:01pm ET

Wall Street heavyweights JPMorgan Chase and General Electric were both involved in healthcare acquisitions reported since yesterday. JPMorgan said today that it has purchased the assets of healthcare transaction processor FisaCure for an undisclosed amount. The financial services giant will integrate FisaCure's receivables and payables technology into the Healthcare Solutions business of JPMorgan Chase's Treasury Services division.

Meanwhile, several published reports indicate that …

... Read more...

ALSO NOTED: Louisville heartcenter opens; "Ad police" hit OTC marketing; and much more...

January 15, 2007 — 8:01pm ET

> Jewish Hospital and the University of Louisville have opened the Cardiovascular Innovation Institute in downtown Louisville, Ky., a $28 million facility to research new treatments for congestive heart failure. Report

> The "advertising police" are cracking down on OTC marketing from Johnson & Johnson, Abbott Laboratories and Pfizer. …

... Read more...

Researchers apologize for disclosure failure

November 7, 2006 — 8:01pm ET

A group of Mayo Clinic-affiliated researchers studying arthritis drugs has publicly apologized for failing to fully disclose financial ties to the pharmaceutical industry. The researchers, who looked at cancer risks among patients taking Remicade, Enbrel and Humira for rheumatoid arthritis, published the results of their study last year in the Journal of the American Medical Association. The researchers didn't disclose, however, that they had let Humira maker …

... Read more...

Cardiologists stand by stents

October 26, 2006 — 8:01pm ET

Recently there have been reports that blood clots can form within drug-coated stents designed to keep arteries clear. But cardiologists at the Transcather Cardiovascular Therapeutics show say patients are "far more are being killed each year by the failure of doctors to promptly clear coronary arteries and install stents when patients arrive at a hospital during a heart attack." Experts say that many studies have proven the superiority of stents to clot-busting drugs, and that the risk of …

... Read more...

Inquiry in backdating scandal broadens

May 18, 2006 — 8:01pm ET

Federal prosecutors announced they are investigating stock options grants at pharmacy benefits manager Caremark Rx, as the corporate backdating scandal gains speed. Shares of UnitedHealth Group fell 3.4 percent yesterday after the company revealed that it is the object of a probe by federal prosecutors. The Wall Street Journal comments: "The entry of the U.S. attorney's office in Manhattan, considered among the most experienced in prosecuting white-collar crimes, signals a …

... Read more...

ALSO NOTED: Microsoft wins Australian contract; Hopkins caves on skin cream; and much more...

April 10, 2006 — 8:00pm ET

> Microsoft has won a $36 million contract to upgrade Australia's e-health infrastructure and build a platform for the country's electronic medical record system. Article

> Guidant's first trial over one of its faulty defibrillators has been postponed. Article

> Johns Hopkins said it is removing …

... Read more...
12next ›last »

Get more Abbott Laboratories coverage at:

FierceHealthFinance